+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

  • ID: 4772350
  • Report
  • 555 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 3M Co
  • CB Scientific Inc
  • Endo International Plc
  • Medherant Ltd
  • Purdue University
  • Thrudermic LLC
  • MORE
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Transdermal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3M Co
  • CB Scientific Inc
  • Endo International Plc
  • Medherant Ltd
  • Purdue University
  • Thrudermic LLC
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Transdermal Drug Delivery Devices Overview

3 Products under Development
3.1 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery Devices - Pipeline Products by Segment
3.3 Transdermal Drug Delivery Devices - Pipeline Products by Territory
3.4 Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery Devices - Ongoing Clinical Trials

4 Transdermal Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Devices Companies and Product Overview
5.1 3M Co Company Overview
5.2 4P Therapeutics LLC Company Overview
5.3 Actuated Medical Inc Company Overview
5.4 Aequus Pharmaceuticals Inc Company Overview
5.5 Agile Therapeutics Inc Company Overview
5.6 Allergan Plc Company Overview
5.7 Alliqua BioMedical Inc Company Overview
5.8 AMW GmbH Company Overview
5.9 AngioSoma Inc Company Overview
5.10 Apogee Technology Inc Company Overview
5.11 Asahi Kasei Pharma Corp Company Overview
5.12 AstraZeneca Plc Company Overview
5.13 Avro Life Sciences Company Overview
5.14 Boryung Pharmaceutical Co Ltd Company Overview
5.15 Burke Pharmaceuticals LLC Company Overview
5.16 Cassava Sciences Inc Company Overview
5.17 CB Scientific Inc Company Overview
5.18 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
5.19 ChemioCare USA Inc Company Overview
5.20 Chrono Therapeutics Inc Company Overview
5.21 Cipla Ltd Company Overview
5.22 Clexio Biosciences Ltd Company Overview
5.23 Corium International Inc Company Overview
5.24 Daewoong Pharmaceutical Co Ltd Company Overview
5.25 DBV Technologies SA Company Overview
5.26 DD Therapeutics LLC Company Overview
5.27 Dermisonics Inc (Inactive) Company Overview
5.28 Dharma Therapeutics, Inc. (Inactive) Company Overview
5.29 Drexel University Company Overview
5.30 DURECT Corp Company Overview
5.31 Echo Therapeutics Inc Company Overview
5.32 Emplicure AB Company Overview
5.33 Endo International Plc Company Overview
5.34 Extend Biosciences Inc Company Overview
5.35 Fe3 Medical Inc Company Overview
5.36 Georgia Institute of Technology Company Overview
5.37 Georgia State University Company Overview
5.38 Hisamitsu Pharmaceutical Co Inc Company Overview
5.39 I.M. Sechenov Moscow State Medical University Company Overview
5.40 Icure Pharmaceutical Inc Company Overview
5.41 ImmuPatch Company Overview
5.42 Indian Institute of Science Company Overview
5.43 Indian Institute of Technology Bombay Company Overview
5.44 InMed Pharmaceuticals Inc Company Overview
5.45 Institute of Materials Research & Engineering Company Overview
5.46 Intercell AG (Inactive) Company Overview
5.47 Interstitial NS Company Overview
5.48 Isis Biopolymer Inc (Inactive) Company Overview
5.49 Janisys Company Overview
5.50 KTH Royal Institute of Technology Company Overview
5.51 LEO Pharma A/S Company Overview
5.52 Lohmann Therapie-Systeme AG Company Overview
5.53 Luye Pharma Group Ltd Company Overview
5.54 Massachusetts Institute of Technology Company Overview
5.55 Mayne Pharma Group Ltd Company Overview
5.56 Medherant Ltd Company Overview
5.57 Medifron DBT Inc Company Overview
5.58 MEDRx Co Ltd Company Overview
5.59 MedRx, Inc. Company Overview
5.60 Microdermics Inc Company Overview
5.61 Micron Biomedical Inc Company Overview
5.62 Micropoint Technologies Pte Ltd Company Overview
5.63 National University of Singapore Company Overview
5.64 Nemaura Pharma Ltd Company Overview
5.65 NeuroDerm Ltd Company Overview
5.66 Nitto Denko Corp Company Overview
5.67 North Carolina State University Company Overview
5.68 Noven Pharmaceuticals Inc Company Overview
5.69 NutriBand Inc Company Overview
5.70 Nuvo Pharmaceuticals Inc Company Overview
5.71 Phosphagenics Ltd Company Overview
5.72 Prometheon Pharma LLC Company Overview
5.73 Purdue University Company Overview
5.74 Radius Health Inc Company Overview
5.75 Scilex Ltd Company Overview
5.76 Seelos Therapeutics Inc Company Overview
5.77 Shenox Pharmaceuticals LLC Company Overview
5.78 Sinsin Pharmaceutical Co Ltd Company Overview
5.79 Skinject Inc Company Overview
5.80 Sparsha Pharma International Pvt Ltd Company Overview
5.81 Sparsha Pharma USA Inc Company Overview
5.82 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.83 Stanford University Company Overview
5.84 Sumitomo Dainippon Pharma Co Ltd Company Overview
5.85 Syntropharma Ltd Company Overview
5.86 Taho Pharmaceuticals Ltd Company Overview
5.87 Teikoku Pharma USA Inc Company Overview
5.88 tesa Labtec GmbH Company Overview
5.89 Teva Pharmaceutical Industries Ltd Company Overview
5.90 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
5.91 TheraJect Inc Company Overview
5.92 Therapeutic Systems Research Laboratories Inc Company Overview
5.93 TheraSolve NV Company Overview
5.94 Theratech, Inc. Company Overview
5.95 Thrudermic LLC Company Overview
5.96 Titan Pharmaceuticals Inc Company Overview
5.97 Toa Eiyo Ltd Company Overview
5.98 Transcu Group Limited (Inactive) Company Overview
5.99 Transdermal Delivery Solutions Corp Company Overview
5.100 Transdermal Specialties Inc Company Overview
5.101 TransPharma Medical Ltd (Inactive) Company Overview
5.102 Transport Pharmaceuticals Inc Company Overview
5.103 Univec, Inc. (Inactive) Company Overview
5.104 University of Illinois at Chicago Company Overview
5.105 University of North Carolina at Chapel Hill School of Medicine Company Overview
5.106 University of Toronto Company Overview
5.107 ViiV Healthcare UK Ltd Company Overview
5.108 Vyteris, Inc. (Inactive) Company Overview
5.109 Xel Pharmaceuticals Inc Company Overview
5.110 Zambon Italia Srl Company Overview
5.111 Z-Cube Srl Company Overview
5.112 ZetrOZ, Inc. Company Overview
5.113 Zosano Pharma Corp Company Overview
5.114 Zynerba Pharmaceuticals Inc Company Overview

6 Transdermal Drug Delivery Devices - Recent Developments
6.1 Apr 29, 2019: ChemioCare announces appointment of Roy F. Waldron to its board of directors
6.2 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
6.3 Apr 25, 2019: The Medicines Company reports first-quarter 2019 financial results and significant progress with the Inclisiran clinical development program
6.4 Apr 25, 2019: DURECT appoints two new board members
6.5 Apr 22, 2019: KalVista Pharmaceuticals names Daniel B. Soland to board of directors
6.6 Apr 19, 2019: Alvogen issues voluntary nationwide recall of Fentanyl Transdermal System due to product mislabeling
6.7 Apr 11, 2019: Sumitomo Dainippon Pharma announces mid-term business plan 2022
6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
6.9 Apr 09, 2019: Revance appoints former Allergan marketing veteran Taryn Conway as Vice President of marketing
6.10 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors

7 Appendix
7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

List of Tables
  • Table 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Table 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
  • Table 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
  • Table 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Table 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
  • Table 7: Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Table 9: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: 3M Hollow Microstructured Transdermal System - Product Status
  • Table 11: 3M Hollow Microstructured Transdermal System - Product Description
  • Table 12: 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: 4P Clonidine Transdermal Patch - Product Status
  • Table 14: 4P Clonidine Transdermal Patch - Product Description
  • Table 15: 4P Scopolamine Transdermal Patch - Product Status
  • Table 16: 4P Scopolamine Transdermal Patch - Product Description
  • Table 17: Defent - Product Status
  • Table 18: Defent - Product Description
  • Table 19: Passive Transdermal Lidocaine Patch - Product Status
  • Table 20: Passive Transdermal Lidocaine Patch - Product Description
  • Table 21: Passive Transdermal Patch - Product Status
  • Table 22: Passive Transdermal Patch - Product Description
  • Table 23: Transdermal Apomorphine Patch - Product Status
  • Table 24: Transdermal Apomorphine Patch - Product Description
  • Table 25: Transdermal Exenatide Patch - Product Status
  • Table 26: Transdermal Exenatide Patch - Product Description
  • Table 27: Transdermal FSH Patch - Product Status
  • Table 28: Transdermal FSH Patch - Product Description
  • Table 29: Transdermal Patch - Diabetes - Product Status
  • Table 30: Transdermal Patch - Diabetes - Product Description
  • Table 31: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: GentleDispense System - Product Status
  • Table 33: GentleDispense System - Product Description
  • Table 34: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: AQS1301 - Product Status
  • Table 36: AQS1301 - Product Description
  • Table 37: AQS1302 - Product Status
  • Table 38: AQS1302 - Product Description
  • Table 39: AQS1303 - Product Status
  • Table 40: AQS1303 - Product Description
  • Table 41: AQS1304 - Product Status
  • Table 42: AQS1304 - Product Description
  • Table 43: Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
  • Table 44: AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
  • Table 45: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: AG200-ER Patch - Product Status
  • Table 47: AG200-ER Patch - Product Description
  • Table 48: AG200-SP Patch - Product Status
  • Table 49: AG200-SP Patch - Product Description
  • Table 50: AG890 Patch - Product Status
  • Table 51: AG890 Patch - Product Description
  • Table 52: Twirla (AG200-15) - Product Status
  • Table 53: Twirla (AG200-15) - Product Description
  • Table 54: Agile Therapeutics Inc - Ongoing Clinical Trials Overview
  • Table 55: Twirla (AG200-15) - Assessing Adhesion with Transdermal and Topical Delivery Systems for ANDAs
  • Table 56: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Nanotechnology-Based Transdermal Delivery System - Product Status
  • Table 58: Nanotechnology-Based Transdermal Delivery System - Product Description
  • Table 59: Norethindrone Transdermal Delivery System - Product Status
  • Table 60: Norethindrone Transdermal Delivery System - Product Description
List of Figures
  • Figure 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
  • Figure 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
  • Figure 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
  • Figure 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
  • Figure 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 3M Co
  • 4P Therapeutics LLC
  • Actuated Medical Inc
  • Aequus Pharmaceuticals Inc
  • Agile Therapeutics Inc
  • Allergan Plc
  • Alliqua BioMedical Inc
  • AMW GmbH
  • AngioSoma Inc
  • Apogee Technology Inc
  • Asahi Kasei Pharma Corp
  • AstraZeneca Plc
  • Avro Life Sciences
  • Boryung Pharmaceutical Co Ltd
  • Burke Pharmaceuticals LLC
  • Cassava Sciences Inc
  • CB Scientific Inc
  • Cerimon Pharmaceuticals, Inc.
  • ChemioCare USA Inc
  • Chrono Therapeutics Inc
  • Cipla Ltd
  • Clexio Biosciences Ltd
  • Corium International Inc
  • Daewoong Pharmaceutical Co Ltd
  • DBV Technologies SA
  • DD Therapeutics LLC
  • Dermisonics Inc
  • Dharma Therapeutics, Inc.
  • Drexel University
  • DURECT Corp
  • Echo Therapeutics Inc
  • Emplicure AB
  • Endo International Plc
  • Extend Biosciences Inc
  • Fe3 Medical Inc
  • Georgia Institute of Technology
  • Georgia State University
  • Hisamitsu Pharmaceutical Co Inc
  • I.M. Sechenov Moscow State Medical University
  • Icure Pharmaceutical Inc
  • ImmuPatch
  • Indian Institute of Science
  • Indian Institute of Technology Bombay
  • InMed Pharmaceuticals Inc
  • Institute of Materials Research & Engineering
  • Intercell AG
  • Interstitial NS
  • Isis Biopolymer Inc
  • Janisys
  • KTH Royal Institute of Technology
  • LEO Pharma A/S
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Massachusetts Institute of Technology
  • Mayne Pharma Group Ltd
  • Medherant Ltd
  • Medifron DBT Inc
  • MEDRx Co Ltd
  • MedRx, Inc.
  • Microdermics Inc
  • Micron Biomedical Inc
  • Micropoint Technologies Pte Ltd
  • National University of Singapore
  • Nemaura Pharma Ltd
  • NeuroDerm Ltd
  • Nitto Denko Corp
  • North Carolina State University
  • Noven Pharmaceuticals Inc
  • NutriBand Inc
  • Nuvo Pharmaceuticals Inc
  • Phosphagenics Ltd
  • Prometheon Pharma LLC
  • Purdue University
  • Radius Health Inc
  • Scilex Ltd
  • Seelos Therapeutics Inc
  • Shenox Pharmaceuticals LLC
  • Sinsin Pharmaceutical Co Ltd
  • Skinject Inc
  • Sparsha Pharma International Pvt Ltd
  • Sparsha Pharma USA Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stanford University
  • Sumitomo Dainippon Pharma Co Ltd
  • Syntropharma Ltd
  • Taho Pharmaceuticals Ltd
  • Teikoku Pharma USA Inc
  • tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • TheraJect Inc
  • Therapeutic Systems Research Laboratories Inc
  • TheraSolve NV
  • Theratech, Inc.
  • Thrudermic LLC
  • Titan Pharmaceuticals Inc
  • Toa Eiyo Ltd
  • Transcu Group Limited
  • Transdermal Delivery Solutions Corp
  • Transdermal Specialties Inc
  • TransPharma Medical Ltd
  • Transport Pharmaceuticals Inc
  • Univec, Inc.
  • University of Illinois at Chicago
  • University of North Carolina at Chapel Hill School of Medicine
  • University of Toronto
  • ViiV Healthcare UK Ltd
  • Vyteris, Inc.
  • Xel Pharmaceuticals Inc
  • Zambon Italia Srl
  • Z-Cube Srl
  • ZetrOZ, Inc.
  • Zosano Pharma Corp
  • Zynerba Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll